164 related articles for article (PubMed ID: 31206200)
1. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
Li W; Zhou Q; Xia S; Wu Y; Fei X; Wang Y; Tao L; Fan J; Zhou W
J Ultrasound Med; 2020 Jan; 39(1):39-50. PubMed ID: 31206200
[TBL] [Abstract][Full Text] [Related]
2. Development of a Multi-Parametric ultrasonography nomogram for prediction of invasiveness in ductal carcinoma in situ.
Niu Q; Li H; Du L; Wang R; Lin J; Chen A; Jia C; Jin L; Li F
Eur J Radiol; 2024 Jun; 175():111415. PubMed ID: 38471320
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities.
Wang B; Yang D; Zhang X; Gong X; Xu T; Han J; Ren Y; Zou S; Li L; Wang Y
Cancer Imaging; 2023 Mar; 23(1):25. PubMed ID: 36899406
[TBL] [Abstract][Full Text] [Related]
4. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
7. The kinetic quantitative characteristics of non-mass breast lesions with contrast-enhanced ultrasound: a prospective study.
Cai YY; Du YC; Zhao L; Hu WJ; Bai Y; Chen A; Du LF; Li F
Br J Radiol; 2023 Dec; 96(1152):20221002. PubMed ID: 37660395
[TBL] [Abstract][Full Text] [Related]
8. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing Breast Ductal Carcinoma In Situ with Microinvasion].
Wu P; Cui L; Guo BH; Wang YC; Cui JS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
[No Abstract] [Full Text] [Related]
9. Application of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Different Molecular Subtypes of Breast Cancer.
Liang X; Li Z; Zhang L; Wang D; Tian J
Ultrason Imaging; 2020 Nov; 42(6):261-270. PubMed ID: 33019918
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results.
Lee SC; Tchelepi H; Grant E; Desai B; Luo C; Groshen S; Hovanessian-Larsen L
J Ultrasound Med; 2019 Sep; 38(9):2259-2273. PubMed ID: 30597640
[TBL] [Abstract][Full Text] [Related]
11. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
Haga M; Hirai T; Nakai T; Kobayashi T; Nakamura T; Marugami A; Ito T; Takewa M; Marugami N; Kichikawa K
J Med Ultrason (2001); 2020 Oct; 47(4):591-601. PubMed ID: 32989596
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
14. The discriminatory diagnostic value of multimodal ultrasound combined with blood cell analysis for granulomatous lobular mastitis and invasive ductal carcinoma of the breast.
Zeng YH; Yang YP; Liu LJ; Xie J; Dai HX; Zhou HL; Huang X; Huang RL; Liu EQ; Deng YJ; Li HJ; Wu JJ; Zhang GL; Liao ML; Xu XH
Clin Hemorheol Microcirc; 2024; 86(4):481-493. PubMed ID: 38007642
[TBL] [Abstract][Full Text] [Related]
15. Features of ductal carcinoma in situ ultrasound images.
Watanabe T
J Med Ultrason (2001); 2023 Jul; 50(3):347-350. PubMed ID: 37369884
[TBL] [Abstract][Full Text] [Related]
16. Non-mass-type ductal carcinoma in situ of the breast on ultrasound: Features and pathological analysis.
Zhang P; Kong P; Liu D; He S; Zhang X
J Cancer Res Ther; 2024 Apr; 20(2):665-668. PubMed ID: 38687938
[TBL] [Abstract][Full Text] [Related]
17. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
19. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.
Ban K; Tsunoda H; Watanabe T; Kaoku S; Yamaguchi T; Ueno E; Hirokaga K; Tanaka K
J Med Ultrason (2001); 2020 Jan; 47(1):107-115. PubMed ID: 31655940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
